作者:
Inamoto,Y. [1]
;
Chai,X. [2]
;
Kurland,B.F. [3]
;
Cutler,C. [4]
;
Flowers,M.E.D. [5]
;
Palmer,J.M. [6]
;
Carpenter,P.A. [7]
;
Heffernan,M.J. [8]
;
Jacobsohn,D. [9]
;
Jagasia,M.H. ;
Pidala,J. ;
Khera,N. ;
Vogelsang,G.B. ;
Weisdorf,D. ;
Martin,P.J. ;
Pavletic,S.Z. ;
Lee,S.J.
作者单位:
Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, United States
[1]
Hematology and Stem Cell Transplant Program, Vanderbilt University Medical Center, Nashville, TN
[2]
National Cancer Institute, Bethesda, MD, United States
[3]
Oncology, Johns Hopkins Hospital, Baltimore, MD, United States
[4]
Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, United States
[5]
Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, United States
[6]
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
[7]
Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, United States
[8]
Division of Blood and Marrow Transplantation, Children's National Medical Center, Center for Cancer
[9]
发布时间
2013-11-20